Showing results (141-150 of 192) with videos related to
Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximabWu Zhang, Michael Gordon, Anne M Schultheis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I studyKatherine K Matthay, Alekist Quach, John Huberty, et al.Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.Journal of the American College of Surgeons|March 2, 2005
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancerSylke Schneider, Kazumi Uchida, Jan Brabender, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committeeLesley Seymour, S Percy Ivy, Daniel Sargent, et al.Journal of Neuroimmunology|September 3, 2004
Increased CXCL8 (IL-8) expression in Multiple SclerosisBrett T Lund, Nazely Ashikian, Huy Q Ta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 statusWalter M Stadler, Seth P Lerner, Susan Groshen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell LymphomaJoseph M Tuscano, Emanual Maverakis, Susan Groshen, et al.Cancer Chemotherapy and Pharmacology|January 10, 2021
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumorsJacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, et al.Journal of Surgical Oncology|July 15, 2015
Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variablesLinda S Sher, David M Levi, Julie S Wecsler, et al.Pageof 20